文献速递细菌感染、耐药与抗菌药物医院感染防控

革兰阴性菌阳性血培养耐药决定因子快速分子检测的系统综述与荟萃分析

Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2019-11-18

该研究系统检索并荟萃分析了2006至2019年间20项研究(3310株分离株),评估Verigene和FilmArray系统直接检测革兰阴性菌阳性血培养中抗菌药物耐药决定因子的性能。汇总显示,与表型对照相比,两系统检测耐药决定因子的合并敏感度为85.3%(95%CI 79.9%-89.4%),特异度为99.1%(95%CI 98.2%-99.5%);与基因型对照相比,敏感度为95.5%(95%CI 89.2%-98.2%),特异度为99.7%(95%CI 99.1%-99.9%)。两系统可作为传统微生物学方法的有效辅助,但FilmArray仅检测KPC一种耐药基因型,且两者在少数病例中可能漏检重要的头孢菌素/碳青霉烯类耐药表型。

要点

  • Verigene和FilmArray检测血培养革兰阴性菌耐药决定因子特异度高(≥99%),敏感度中等至较高。
  • FilmArray仅检测KPC,限制其应用范围;两系统均可能漏检少数耐药表型。
  • 快速分子检测可作为传统微生物学方法的有效辅助,助力及时识别耐药菌。

核心结论

  • Verigene和FilmArray系统可作为传统微生物学方法识别革兰阴性菌耐药性的有效辅助工具。
  • FilmArray仅检测KPC一种耐药基因型,限制了其使用。
  • 两系统在少数病例中可能漏检重要的头孢菌素/碳青霉烯类耐药表型。
  • 两系统的敏感度和特异度使其成为及时识别耐药分离株的有价值临床工具。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Scopus和ISI Web of Knowledge数据库。
  • 共纳入20项研究(3310株分离株),发表于2006至2019年,其中9项研究在东亚进行。
  • 15项研究使用表型对照(1930株分离株),5项研究使用基因型对照(1380株分离株)。
  • 采用双变量随机效应模型汇总敏感度和特异度。

主要发现

  • 表型对照研究中,1014株(52.5%)为大肠埃希菌,287株(14.9%)显示耐药表型。
  • 基因型对照研究中,585株(42.4%)为大肠埃希菌,100株(7.2%)显示耐药基因型。
  • 15项表型对照研究汇总敏感度85.3%(95%CI 79.9%-89.4%),特异度99.1%(95%CI 98.2%-99.5%)。
  • 5项基因型对照研究汇总敏感度95.5%(95%CI 89.2%-98.2%),特异度99.7%(95%CI 99.1%-99.9%)。

关键数值与推荐

  • Verigene检测CTX-M、IMP、KPC、NDM、OXA和VIM;FilmArray检测KPC。
  • 纳入标准为评估Verigene和/或FilmArray系统对革兰阴性菌阳性血培养快速检测性能的临床研究。
  • 对照方法为对革兰阴性菌阳性血培养分离株进行的表型或基因型方法。

临床怎么用

  • 快速分子检测可作为传统微生物学方法的辅助,用于及时识别血培养革兰阴性菌的耐药决定因子。
  • FilmArray仅检测KPC,应用范围有限,需结合临床需要选择。
  • 应知晓两系统在少数病例中可能漏检重要的头孢菌素/碳青霉烯类耐药表型。

局限性

  • 研究仅评估Verigene和FilmArray两种商业系统。
  • FilmArray仅检测KPC一种耐药基因型。
  • 两系统在少数病例中可能漏检重要的耐药表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Timely detection of antimicrobial (cephalosporin/carbapenem) resistance (AMR) determinants is crucial to the clinical management of bloodstream infections caused by Gram-negative bacteria (GNB). OBJECTIVES: To review and meta-analyse the evidence for using commercially available molecular tests for the direct detection of AMR determinants in GNB-positive blood cultures (PBCs). DATA SOURCES: PubMed, Scopus and ISI Web of Knowledge. STUDY ELIGIBILITY CRITERIA: Clinical studies evaluating the performance of two major commercial systems, namely the Verigene® and FilmArray® systems, for rapid testing of GNB-PBCs, in comparison with the phenotypic or genotypic methods performed on GNB-PBC isolates. METHODS: Literature search according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria and, for meta-analysis of sensitivity and specificity of both systems, bivariate random-effects model. RESULTS: Twenty studies were identified (3310 isolates) from 2006 to 2019. Nine studies were conducted in East Asia. In 15 studies using phenotypic comparators (1930 isolates), 1014 (52.5%) isolates were Escherichia coli, and 287 (14.9%) of all the isolates displayed AMR phenotypes. In five studies using genotypic comparators (1380 isolates), 585 (42.4%) were E. coli, and 100 (7.2%) of all the isolates displayed AMR genotypes. Pooled sensitivity and specificity estimates for detection of AMR determinants by the Verigene (i.e. CTX-M, IMP, KPC, NDM, OXA and VIM) and/or FilmArray (i.e. KPC) systems were 85.3% (95% CI 79.9%-89.4%) and 99.1% (95% CI 98.2%-99.5%), respectively, across the 15 studies, and 95.5% (95% CI 89.2%-98.2%) and 99.7% (95% CI 99.1%-99.9%), respectively, across the five studies. CONCLUSIONS: Our findings show that the Verigene and FilmArray systems may be a valid adjunct to the conventional microbiology (phenotypic or genotypic) methods used to identify AMR in GNBs. The FilmArray system detects only one AMR genotype, namely KPC, limiting its use. Both Verigene and FilmArray systems can miss important cephalosporin/carbapenem resistance phenotypes in a minority of cases. However, the sensitivity and specificity of both systems render them valuable clinical tools in timely identification of resistant isolates. Further studies will establish the prominence of such rapid diagnostics as standard of care in individuals with bloodstream infections.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. De Angelis G, Grossi A, Menchinelli G, et al. Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis. Clin Microbiol Infect. 2019. PMID: 31751768. doi:10.1016/j.cmi.2019.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。